Related Experiment Video
Updated: May 5, 2026

08:53
In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
Published on: September 16, 2019
8.9K
Monoclonal antibodies: application in radiopharmacy
Thais Braga Ligiero, Marta de Souza Albernaz, Samira Marques de Carvalho
1Nuclear Enginnering Institute, Rua Helio de Almeida, 75, Rio de Janeiro, Brazil. roliveira@ien.gov.br.
Current Radiopharmaceuticals
|November 21, 2013
Abstract:
In this study was carried on a systematic review of the data was carried out in the topic of monoclonal antibodies in the last 40 years. All the data collected and summarized revealed that this new class of medicine may bring great advance in the field of radiopharmacy, oncology and imaging.
Related Concept Videos
Hybridoma Technology
13.2K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.2K
Imaging Studies II: Positron Emission Tomography and Scintigraphy
861
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
861

